Manufacturer record
Pharma Force Lab (Unit-II): regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Pharma Force Lab (Unit-II) (Himachal Pradesh) were declared Not of Standard Quality between February 2022 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: E9AIY029, Montelukast & Levocetirizine Dihydrochloride (exp Jul 2027). FDTL,Uttarakhand (state lab) found it not of standard quality: Assay of Montelukast Sodium IP & Levocetirizine Dihydrochloride IP. Listed in the February 2026 alert.
Records by type
3 records linked to Pharma Force Lab (Unit-II) in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Montelukast & Levocetirizine Dihydrochloride | Batch E9AIY029Mfg Aug 2025 · Exp Jul 2027 | Assay of Montelukast Sodium IP & Levocetirizine Dihydrochloride IPAssay | FDTL,UttarakhandState lab | Feb 2026 |
| Sucralfate and Oxetacaine Oral Suspension (1g, 20mg/10ml) (SUCRAMAL-O SUSPENSION) | Batch P2AWU002Mfg Jun 2021 · Exp May 2023 | Assay of OxetacaineAssay | RDTL ChandigarhState lab | Feb 2022 |
| Sucralfate and Oxetacaine Oral Suspension (1g, 20mg/10 ml) (SUCRAMAL- O SUSPENSION) | Batch P2AWU001Mfg Jun 2021 · Exp May 2023 | Assay of OxetacaineAssay | RDTL ChandigarhState lab | Feb 2022 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| L-Carnitine, L- Tartarate ,Mecobalamin & Folic Acid Tablets | B95Y032 | SDTL, Assam | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Apr 2026 |
| Trypsin-Chymotrypsin Tablets | 2KU6L055 | FDAL Maharashtra | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Jan 2026 |
| Deflazacort Tablets 6 mg Defcort 6 | 13240334A | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.